These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 2220797

  • 21. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED, Preddie DC.
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [Abstract] [Full Text] [Related]

  • 22. [New antihypertensive therapy in diabetics].
    Passa P, Marre M, Leblanc H, Billault B.
    Diabete Metab; 1987; 13(6):643-50. PubMed ID: 3329128
    [Abstract] [Full Text] [Related]

  • 23. Hypertension in the elderly diabetic: therapeutic aspects.
    Frank HJ.
    J Hypertens Suppl; 1988 Nov; 6(1):S109-11. PubMed ID: 3063784
    [Abstract] [Full Text] [Related]

  • 24. Hypertension and insulin resistance.
    Prichard BN, Smith CC, Sen S, Betteridge DJ.
    J Cardiovasc Pharmacol; 1992 Nov; 20 Suppl 11():S77-84. PubMed ID: 1284147
    [Abstract] [Full Text] [Related]

  • 25. [The pathogenesis of arterial hypertension in diabetes mellitus and its role in nephropathy].
    Raimondi C, Castiglioni A, Allergri L, Bocchi B, Orsini S, Vinci S, Savazzi GM.
    Recenti Prog Med; 1990 Dec; 81(12):782-7. PubMed ID: 2075280
    [Abstract] [Full Text] [Related]

  • 26. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 27. Hypertension and prognosis in established diabetic nephropathy.
    O'Hare JP.
    J Hum Hypertens; 1991 Aug; 5(4):265-71. PubMed ID: 1956024
    [Abstract] [Full Text] [Related]

  • 28. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
    Zukowska-Szczechowska E, Tomaszewski M, Grzeszczak W.
    Przegl Lek; 2001 Aug; 58(3):124-6. PubMed ID: 11475857
    [Abstract] [Full Text] [Related]

  • 29. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P.
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [Abstract] [Full Text] [Related]

  • 32. [Diabetes and hypertension].
    Sayk F, Iwen KA, Lehnert H.
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2296-301. PubMed ID: 19876807
    [Abstract] [Full Text] [Related]

  • 33. [Hypertension associated with diabetes: inquiry into the attitudes and behaviors of French physicians].
    Passa P, Mallion JM, Vasmant D, Saint-Paul D, Dreyfus JP, Tordjman E, Doan Tran D.
    Diabete Metab; 1992 Nov; 18(2 Pt 2):170-81. PubMed ID: 1639205
    [Abstract] [Full Text] [Related]

  • 34. [Hypertension, insulin resistance and diabetes mellitus: pathophysiological interactions and therapeutic consequences].
    Schernthaner G.
    Wien Klin Wochenschr; 1990 Dec 21; 102(24):707-12. PubMed ID: 1980767
    [Abstract] [Full Text] [Related]

  • 35. Diuretics and diabetes incidence--an appeal against the reluctance to prescribe a medication that is safe and proven.
    Siebenhofer A, Jeitler K, Rakovac I, Horvath K.
    Diabet Med; 2010 Feb 21; 27(2):130-5. PubMed ID: 20546254
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of hypertension in diabetes: threshold of intervention and therapeutic options].
    Plouin PF, Lebrun P, Azizi M, Day M.
    Diabete Metab; 1992 Feb 21; 18(2 Pt 2):182-6. PubMed ID: 1639206
    [Abstract] [Full Text] [Related]

  • 37. The future of calcium channel blocker therapy in diabetes mellitus.
    Savage S, Miller LA, Schrier RW.
    J Cardiovasc Pharmacol; 1991 Feb 21; 18 Suppl 1():S19-24. PubMed ID: 1723450
    [Abstract] [Full Text] [Related]

  • 38. [Diabetic nephropathy and arterial hypertension: the physiopathological aspects and antihypertensive treatment].
    Savazzi GM, Castiglioni A.
    Ann Ital Med Int; 1992 Feb 21; 7(3):160-4. PubMed ID: 1457255
    [Abstract] [Full Text] [Related]

  • 39. [Converting enzyme inhibitors in diabetes].
    Marre M.
    Rev Prat; 1992 Dec 15; 42(20):2574-7. PubMed ID: 1299943
    [Abstract] [Full Text] [Related]

  • 40. Incidence of diabetes during antihypertensive treatment.
    Bengtsson C.
    Horm Metab Res Suppl; 1990 Dec 15; 22():38-42. PubMed ID: 1975245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.